Evaluating the Peterson Health Technology Institute’s Role in Shaping Digital Health Technology Assessments and Payer Impact
As many new promising digital health tech solutions enter the market, agencies like the Peterson Health Technology Institute (PHTI) have begun independent, evidence-based evaluations on the value and cost-effectiveness of these technologies. What difference will these assessments make to decisions by US payers on coverage?
This report examines the influence of PHTI's assessments on payer decisions, healthcare access and evidence standards. It provides detailed insights into the value and cost-effectiveness of digital diabetes management and virtual musculoskeletal solutions. Additionally, the report explores the collaboration between PHTI and the Institute for Clinical and Economic Review (ICER), offering a comprehensive understanding of how these evaluations shape market access and payer funding. Gain valuable knowledge on the evolving landscape of digital health tech assessments and their implications for the industry.